Insider Ledger
FOLD insider buying and SEC filings, explained
Amicus Therapeutics, Inc. · CIK 1178879
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Industry (SIC)
- Pharmaceutical Preparations
- State of incorporation
- DE
- Fiscal year end
- Dec 31
- Former names
- AMICUS THERAPEUTICS INC
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$5.4M
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Mar 2, 2026 | Planned (10b5-1) | Bradley L Campbell (CEO and Director) sold 22,500 shares at about $14.35 ($323K), marked as a 10b5-1 plan trade. Holdings down 2% to 998,680 shares. | SEC filing Filed Mar 4, 2026 |
| Jan 20, 2026 | Planned (10b5-1) | Bradley L Campbell (CEO and Director) sold 75,000 shares at about $14.31 ($1.1M), marked as a 10b5-1 plan trade. Holdings down 7% to 1,021,180 shares. | SEC filing Filed Jan 22, 2026 |
| Dec 19, 2025 | Planned (10b5-1) | David Michael Clark (Chief People Officer) sold 25,642 shares at $14.17 ($363K), marked as a 10b5-1 plan trade. Holdings down 9% to 245,690 shares. | SEC filing Filed Dec 23, 2025 |
| Dec 15, 2025 | Planned (10b5-1) | Bradley L Campbell (CEO and Director) sold 77,926 shares at about $10.86 ($846K), marked as a 10b5-1 plan trade. Holdings down 6% to 1,129,782 shares. | SEC filing Filed Dec 17, 2025 |
| Dec 15, 2025 | Planned (10b5-1) | David Michael Clark (Chief People Officer) sold 25,643 shares at $11.00 ($282K), marked as a 10b5-1 plan trade. Holdings down 9% to 271,332 shares. | SEC filing Filed Dec 17, 2025 |
| Dec 1, 2025 | Planned (10b5-1) | Bradley L Campbell (CEO and Director) sold 14,587 shares at about $10.01 ($146K), marked as a 10b5-1 plan trade. Holdings down 1% to 1,137,282 shares. | SEC filing Filed Dec 3, 2025 |
| Nov 24, 2025 | Planned (10b5-1) | Jeff Castelli (Chief Development Officer) sold 76,158 shares at about $10.16 ($774K), marked as a 10b5-1 plan trade. Holdings down 15% to 439,318 shares. | SEC filing Filed Nov 26, 2025 |
| Nov 24, 2025 | Planned (10b5-1) | David Michael Clark (Chief People Officer) sold 25,643 shares at about $10.10 ($259K), marked as a 10b5-1 plan trade. Holdings down 8% to 296,975 shares. | SEC filing Filed Nov 26, 2025 |
| Nov 24, 2025 | Planned (10b5-1) | Bradley L Campbell (CEO and Director) sold 14,587 shares at about $10.04 ($146K), marked as a 10b5-1 plan trade. Holdings down 1% to 1,137,282 shares. | SEC filing Filed Nov 26, 2025 |
| Nov 24–26, 2025 | Planned (10b5-1) | Ellen Rosenberg (Chief Legal Officer) sold 95,621 shares between Nov 24, 2025 and Nov 26, 2025 at about $10.02 ($958K), marked as a 10b5-1 plan trade. Holdings down 16% to 507,710 shares. | SEC filing Filed Nov 26, 2025 |
| Nov 4, 2025 | Planned (10b5-1) | David Michael Clark (Chief People Officer) sold 25,643 shares at about $9.51 ($244K), marked as a 10b5-1 plan trade. Holdings down 7% to 322,618 shares. | SEC filing Filed Nov 5, 2025 |
27 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow FOLD in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.